Forte Biosciences, Inc. (FBRX)

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Forte Biosciences stock have an average target of 61, which predicts a 476.02% increase from the current stock price of 10.59.

Price Target: $61 (+476.02%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$61	$61	$61	$61
Change	+476.02%	+476.02%	+476.02%	+476.02%

Analyst Ratings

The average analyst rating for Forte Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	4	4	4	4	4	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy Maintains $61	Strong Buy	Maintains	$61	+476.02%	Jun 24, 2025
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy Maintains $64 → $61	Strong Buy	Maintains	$64 → $61	+476.02%	Apr 1, 2025
Yaron Werber TD Cowen	TD Cowen	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Jan 21, 2025
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy Maintains $64	Strong Buy	Maintains	$64	+504.34%	Dec 4, 2024
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy Maintains $3 → $64	Strong Buy	Maintains	$3 → $64	+504.34%	Nov 15, 2024

More Analyst Ratings

Financial Forecast

• Revenue Next Year:
  n/a
• EPS This Year:
  -3.74

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	-	-	66.18M
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-157.93	-38.85	-19.96	-24.92	-12.17	-3.74	-2.80	-3.13
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-3.51	-2.14	-2.50
Avg	-3.74	-2.80	-3.13
Low	-4.17	-3.26	-3.68

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.